Silence Therapeutics (OTCMKTS:SLNCF – Get Free Report) is one of 383 public companies in the “Biotechnology” industry, but how does it contrast to its rivals? We will compare Silence Therapeutics to similar companies based on the strength of its profitability, dividends, valuation, analyst recommendations, institutional ownership, earnings and risk. Insider & Institutional Ownership 7.9% of […]